Thrombotic Complications and Hypercoagulability associated with COVID-19 Infection
From ConsultQD Live Admin2 on July 7th, 2020
- Introduction by Moderator: Deborah Hornacek, MD
- Case Presentation: Deborah Hornacek, MD
- Incidence and Types of Thrombosis: G. Jay Bishop, MD
- Pathophysiology of hypercoagulability in COVID-19: Scott Cameron, MD, PhD
- Laboratory Data: Kandice Marchant, MD, PhD
- Treatment and Prevention of Thrombosis: Marcelo Gomes, MD
- Advanced Therapies: Interventional Options with Considerations for COVID-19 Patients: Joseph Campbell, MD
- Assess appropriate evaluations and interventions to prevent or treat thrombosis
- Describe pathophysiology and increased thrombotic risk associated with COVID-19
- Identify advanced therapies and interventional options for thrombotic complications
This online series is designed for physicians, allied health practitioners and students interested in complex cardiovascular and thoracic conditions.
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME. The following faculty has indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest: Joseph Campbell, MD, Deborah Hornacek, MD, Gerald Jay Bishop, MD, Scott James Cameron, MD, Kandice Marchant, MD, PhD, Marcelo P Gomes, MD
The following faculty has indicated that they may have a relationship, which in the context of their presentation(s) could be perceived as a potential conflict of interest: Eric E Roselli, MD, Activity Director: Cook Medical - Teaching and Speaking. Abbott - Teaching and Speaking. Cryolife, Inc. -Consulting. Edwards Lifesciences - Teaching and Speaking. LivaNova, PLC - Consulting, Teaching and Speaking. Medtronic - Consulting. Terumo - Teaching and Speaking. W.L. Gore & Associates – Consulting.
For further information about this activity, contact Katie Breznai at email@example.com